<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">cardiotomsk</journal-id><journal-title-group><journal-title xml:lang="ru">Сибирский журнал клинической и экспериментальной медицины</journal-title><trans-title-group xml:lang="en"><trans-title>Siberian Journal of Clinical and Experimental Medicine</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2713-2927</issn><issn pub-type="epub">2713-265X</issn><publisher><publisher-name>TSU publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.29001/2073-8552-2023-38-4-106-115</article-id><article-id custom-type="elpub" pub-id-type="custom">cardiotomsk-2059</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>КЛИНИЧЕСКИЕ ИССЛЕДОВАНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>CLINICAL STUDIES</subject></subj-group></article-categories><title-group><article-title>Анализ электротерапии у пациентов с имплантированным кардиовертером-дефибриллятором для первичной профилактики внезапной сердечной смерти по данным удаленного мониторинга</article-title><trans-title-group xml:lang="en"><trans-title>Analysis of electrotherapy in patients with implantable cardioverter-defibrillator for primary prevention of sudden cardiac death according to remote monitoring data</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0507-096X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Лебедева</surname><given-names>В. К.</given-names></name><name name-style="western" xml:lang="en"><surname>Lebedeva</surname><given-names>V. K.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Лебедева Виктория Кимовна, д-р мед. наук, ведущий научный сотрудник, научно-исследовательский отдел аритмологии; профессор кафедры кардиологии, Институт медицинского образования</p><p>197341, Санкт-Петербург, ул. Аккуратова, 2</p><p> </p></bio><bio xml:lang="en"><p>Viktoriia K. Lebedeva, Dr. Sci. (Med.), Leading Research Scientist, Department of Arythmology V.A. Almazov National Medical Research Center, Professor of IMO Cardiology Department</p><p>2, Akkuratova St., St. Petersburg, 197341</p></bio><email xlink:type="simple">lebedevavikt@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0008-6712-0476</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Левинова</surname><given-names>О. Э.</given-names></name><name name-style="western" xml:lang="en"><surname>Levinova</surname><given-names>O. E.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Левинова Оксана Эдуардовна, лаборант-исследователь; ординатор, кафедра факультетской терапии с клиникой, Институт медицинского образования</p><p>197341, Санкт-Петербург, ул. Аккуратова, 2</p><p> </p></bio><bio xml:lang="en"><p>Oksana E. Levinova, Research Assistant, Resident, Department of Faculty of Internal Medicine with Clinic</p><p>2, Akkuratova St., St. Petersburg, 197341</p></bio><email xlink:type="simple">levinova_oe@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Национальный медицинский исследовательский центр имени В.А. Алмазова Министерства здравоохранения Российской Федерации</institution><country>Россия</country></aff><aff xml:lang="en"><institution>V.A. Almazov National Medical Research Center of Ministry of Health of the Russian Federation</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2023</year></pub-date><pub-date pub-type="epub"><day>30</day><month>12</month><year>2023</year></pub-date><volume>38</volume><issue>4</issue><fpage>106</fpage><lpage>115</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Лебедева В.К., Левинова О.Э., 2023</copyright-statement><copyright-year>2023</copyright-year><copyright-holder xml:lang="ru">Лебедева В.К., Левинова О.Э.</copyright-holder><copyright-holder xml:lang="en">Lebedeva V.K., Levinova O.E.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.sibjcem.ru/jour/article/view/2059">https://www.sibjcem.ru/jour/article/view/2059</self-uri><abstract><sec><title>Цель</title><p>Цель: определить факторы, ассоциированные с развитием обоснованных и необоснованных срабатываний имплантируемых кардиовертеров-дефибрилляторов (ИКД), у пациентов с высоким риском внезапной сердечной смерти (ВСС) на основании данных системы удаленного мониторинга.</p></sec><sec><title>Материал и методы</title><p>Материал и методы. Выполнен анализ данных удаленного мониторирования с 2014 по 2022 гг. у 132 пациентов с ИКД для первичной профилактики ВСС. Пациенты были разделены на 2 группы: группа 1 – пациенты с зарегистрированными устойчивыми пароксизмами тахиаритмий; группа 2 – пациенты без детекции стойких пароксизмов желудочковой тахикардии / фибрилляции желудочков (ЖТ / ФЖ). В случае необоснованных срабатываний ИКД проводился анализ причин и возможных предикторов их возникновения.</p></sec><sec><title>Результаты</title><p>Результаты. Из 132 пациентов у 62 (46,9%) пациентов были получены данные о детекции стойких ЖТ / ФЖ. Выявлено, что вероятность детекции устойчивых пароксизмов ЖТ / ФЖ снижается при наличии реваскуляризации в анамнезе (p = 0,030) и повышается при отсутствии терапии амиодароном (р = 0,012), с увеличением возраста (р = 0,035), при снижении фракции выброса (ФВ) левого желудочка (ЛЖ) менее 35% (р = 0,016). 71 (17,9%) аритмический эпизод у 27 (20,4%) пациентов был расценен как ложная детекция тахиаритмий. При анализе причин необоснованной электротерапии чаще отмечены различные виды наджелудочковых тахиаритмий в зоне детекции ЖТ (85,9%), в т. ч. фибрилляция предсердий (25,4%), в меньшем проценте случаев выявлена детекция Т-волны 4,2%, шум на электроде – 2,8%, 7,1% – двойной счетчик за счет работы устройства модуляции сердечной сократимости. При анализе факторов, ассоциированных с ложной детекцией эпизодов, были получены статистически значимые результаты в отношении наличия в анамнезе фибрилляции предсердий (р = 0,036), имплантированного однокамерного ИКД (р = 0,028).</p></sec><sec><title>Заключение</title><p>Заключение. У 47% пациентов с ИКД для первичной профилактики ВСС отмечалось развитие стойких желудочковых тахиаритмий, у 20,4% имела место ложная детекция эпизодов и неуместная электротерапия. Выявлены предикторы их возникновения, что может быть использовано для разработки стратегии минимизации шоковых воздействий.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Aim</title><p>Aim: To determine the factors associated with development of justified and inappropriate implantable cardioverter-defibrillator (ICD) activations in patients at high risk of sudden cardiac death based on the remote monitoring system</p></sec><sec><title>Material and Methods</title><p>Material and Methods. We analyzed remote monitoring data from 2014 to 2022 in 132 patients with ICD for primary prevention of sudden cardiac death (SCD). Patients were divided into 2 groups 1 – patients with persistent paroxysmal tachyarrhythmias; 2 – patients without persistent paroxysms of ventricular tachycardia (VT) / ventricular fibrillation (VF). In case of inappropriate shocks, the causes and possible predictors of their development were analyzed.</p></sec><sec><title>Results</title><p>Results. Of 132 patients, 62 (46.9%) patients appeared to have persistent VT/VF. It was found that the probability of detecting persistent paroxysms of VT/VF decreased with a history of revascularization (p = 0.030) and increased in the absence of amiodarone therapy (p = 0.012), with increasing age (p = 0.035), with decreasing left ventricular ejection fraction (LVEF) less than 35% (p = 0.016). 71 arrhythmic episodes (17.9%) in 27 (20.4%) patients were considered as false detection of tachyarrhythmias. Analyzing the causes of inappropriate electrotherapy, different types of supraventricular tachyarrhythmias in the zone of VT detection (85.9%), including atrial fibrillation (25.4%), in smaller percentage of cases there was discovered T-wave detection 4.2%, noise on the electrode – 2.8%, 7.1% – double counter due to the operation of the cardiac contractility modulation device. When analyzing factors associated with the development of false detection, reliable results were obtained with regard to the presence of a history of atrial fibrillation (p = 0.036), implanted single-chamber ICD (p = 0.028).</p></sec><sec><title>Conclusion</title><p>Conclusion. The development of persistent ventricular tachyarrhythmias was noted in 47% of patients with ICD as a part of primary prevention of sudden cardiac death, and 20.4% had the development of inappropriate detection and electrotherapy. Predictors of their occurrence have been identified, which can be used as development of strategies for shock minimization.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>внезапная сердечная смерть</kwd><kwd>имплантируемый кардиовертер-дефибриллятор</kwd><kwd>электротерапия</kwd><kwd>необоснованный шок</kwd></kwd-group><kwd-group xml:lang="en"><kwd>sudden cardiac death</kwd><kwd>implantable cardioverter-defibrillator</kwd><kwd>electrotherapy</kwd><kwd>inappropriate shock</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Barisone M., Hayter M., Ghirotto L., Catania G., Zanini M., Dal Molin A. et al. The experience of patients with an implantable cardioverter-defibrillator: a systematic review and meta-synthesis of qualitative studies. Eur. J. Cardiovasc. Nurs. 2022;21(7):677–686. DOI: 10.1093/eurjcn/zvab135.</mixed-citation><mixed-citation xml:lang="en">Barisone M., Hayter M., Ghirotto L., Catania G., Zanini M., Dal Molin A. et al. The experience of patients with an implantable cardioverter-defibrillator: a systematic review and meta-synthesis of qualitative studies. Eur. J. Cardiovasc. Nurs. 2022;21(7):677–686. DOI: 10.1093/eurjcn/zvab135.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Fleeman B.E. Aleong R.G. Optimal strategies to reduce inappropriate implantable cardioverter-defibrillator shocks. Innov. Card. Rhythm. Manag. 2019;10(4):3623–3632. DOI: 10.19102/icrm.2019.100403.</mixed-citation><mixed-citation xml:lang="en">Fleeman B.E. Aleong R.G. Optimal strategies to reduce inappropriate implantable cardioverter-defibrillator shocks. Innov. Card. Rhythm. Manag. 2019;10(4):3623–3632. DOI: 10.19102/icrm.2019.100403.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Stiles M.K., Fauchier L., Morillo C.A., Wilkoff B.L. 2019 HRS/EHRA/ APHRS/LAHRS focused update to 2015 expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing. Heart Rhythm. 2020;17(1):220–228. DOI: 10.1016/j.hrthm.2019.02.03.</mixed-citation><mixed-citation xml:lang="en">Stiles M.K., Fauchier L., Morillo C.A., Wilkoff B.L. 2019 HRS/EHRA/ APHRS/LAHRS focused update to 2015 expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing. Heart Rhythm. 2020;17(1):220–228. DOI: 10.1016/j.hrthm.2019.02.03.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Joung B. Lexcen D., Ching C., Silver M., Piccini J., Sterns L. et al. Additional antitachycardia pacing programming strategies further reduce unnecessary implantable cardioverter-defibrillator shocks. Heart Rhythm. 2020;17(1):98–105. DOI: 10.1016/j.hrthm.2019.07.027.</mixed-citation><mixed-citation xml:lang="en">Joung B. Lexcen D., Ching C., Silver M., Piccini J., Sterns L. et al. Additional antitachycardia pacing programming strategies further reduce unnecessary implantable cardioverter-defibrillator shocks. Heart Rhythm. 2020;17(1):98–105. DOI: 10.1016/j.hrthm.2019.07.027.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Tan V., Wilton S., Kuriachan V., Sumner G., Exner D. Impact of programming strategies aimed at reducing nonessential implantable cardioverter defibrillator therapies on mortality: a systematic review and meta-analysis. Circ. Arrhythm. Electrophysiol. 2014; 7(1):164–70. DOI: 10.1161/CIRCEP.113.001217.</mixed-citation><mixed-citation xml:lang="en">Tan V., Wilton S., Kuriachan V., Sumner G., Exner D. Impact of programming strategies aimed at reducing nonessential implantable cardioverter defibrillator therapies on mortality: a systematic review and meta-analysis. Circ. Arrhythm. Electrophysiol. 2014; 7(1):164–70. DOI: 10.1161/CIRCEP.113.001217.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Iannaccone M., Nombela-Franco L., Gallone G., Annone U., Di Marco A., Giannini F. et al. Impact of successful chronic coronary total occlusion recanalization on recurrence of ventricular arrhythmias in implantable cardioverter-defibrillator recipients for ischemic cardiomyopathy (VACTO PCI Study). Cardiovasc. Revasc. Med. 2022;43:104–111. DOI: 10.1016/j.carrev.2022.03.029.</mixed-citation><mixed-citation xml:lang="en">Iannaccone M., Nombela-Franco L., Gallone G., Annone U., Di Marco A., Giannini F. et al. Impact of successful chronic coronary total occlusion recanalization on recurrence of ventricular arrhythmias in implantable cardioverter-defibrillator recipients for ischemic cardiomyopathy (VACTO PCI Study). Cardiovasc. Revasc. Med. 2022;43:104–111. DOI: 10.1016/j.carrev.2022.03.029.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Barsheshet A., Goldenberg I., Moss A., Huang D., Zareba W., McNITT S. Effect of elapsed time from coronary revascularization to implantation of a Cardioverter defibrillator on long-term survival in the MADIT-II trial. J. Cardiovasc. Electrophysiol. 2011;22(11):1237–1242. DOI: 10.1111/j.1540-8167.2011.02096.</mixed-citation><mixed-citation xml:lang="en">Barsheshet A., Goldenberg I., Moss A., Huang D., Zareba W., McNITT S. Effect of elapsed time from coronary revascularization to implantation of a Cardioverter defibrillator on long-term survival in the MADIT-II trial. J. Cardiovasc. Electrophysiol. 2011;22(11):1237–1242. DOI: 10.1111/j.1540-8167.2011.02096.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Ursaru A.M., Petris A., Costache I. Comparable efficacy in ischemic and non-ischemic ICD recipients for the primary prevention of sudden cardiac death. Biomedicines. 2021;9(11):1595. DOI: 10.3390/biomedicines9111595.</mixed-citation><mixed-citation xml:lang="en">Ursaru A.M., Petris A., Costache I. Comparable efficacy in ischemic and non-ischemic ICD recipients for the primary prevention of sudden cardiac death. Biomedicines. 2021;9(11):1595. DOI: 10.3390/biomedicines9111595.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Илов Н.Н., Пальникова О.В., Стомпель Д.Р., Нечепуренко А.А. Клинические предикторы возникновения желудочковых тахиаритмий у больных со сниженной систолической функцией левого желудочка. Результаты одноцентрового проспективного исследования. Кардиология. 2021;61(5):32–40.. DOI: 10.18087/cardio.2021.5.n1480.</mixed-citation><mixed-citation xml:lang="en">Ilov N.N., Palnikova O.V., Stompel D.R., Nechepurenko А.A. Clinical predictors of occurrence of ventricular tachyarrhythmias in patients with reduced left ventricle ejection fraction. results of single-center prospective study. Kardiologiia. 2021;61(5):32–40. (In Russ.). DOI: 10.18087/cardio.2021.5.n1480.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Лебедева В.К., Любимцева Т.А., Лебедев Д.С. Анализ электротерапии кардиовертерами-дефибрилляторами, имплантируемыми с целью первичной профилактики внезапной сердечной смерти. Российский кардиологический журнал. 2019;(7):26–32. DOI: 10.15829/1560-4071-2019-7-26-32.</mixed-citation><mixed-citation xml:lang="en">Lebedeva V.K., Lyubimtseva T.A., Lebedev D.S. Analysis of electrotherapy of cardioverter defibrillators implanted for the primary prevention of sudden cardiac death. Russian Journal of Cardiology. 2019;(7):26–32. (In Russ.). DOI: 10.15829/1560-4071-2019-7-26-32.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Чугунов И.А., Мареев Ю.В., Фудим М., Миронова Н.А., Мареев В.Ю., Давтян К.В. Модуляция сердечной сократимости в лечении пациентов с сердечной недостаточностью со сниженной фракцией выброса левого желудочка. Кардиология. 2022: 62(11):71–78. DOI: 10.18087/cardio.2022.11.n2014.</mixed-citation><mixed-citation xml:lang="en">Chugunov I.A., Mareev Yu.V., Fudim M., Mironova N.A., Mareev V.Yu., Davtyan R.V. Cardiac contractility modulation in heart failure with reduced ejection fraction treatment. Kardiologiia. 2022;62(11):71–78. (In Russ.). DOI: 10.18087/cardio.2022.11.n2014.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Oosterwerff E., Adiyaman A., Elvan A., Ghani A., Hoek L., Breeman K. et al. Significantly less inappropriate shocks in ischemic patients compared to non-ischemic patients: The S-ICD experience of a high volume single-center. Pacing Clin. Electrophysiol. 2021;44(11):1918–1924. DOI: 10.1111/pace.14364.</mixed-citation><mixed-citation xml:lang="en">Oosterwerff E., Adiyaman A., Elvan A., Ghani A., Hoek L., Breeman K. et al. Significantly less inappropriate shocks in ischemic patients compared to non-ischemic patients: The S-ICD experience of a high volume single-center. Pacing Clin. Electrophysiol. 2021;44(11):1918–1924. DOI: 10.1111/pace.14364.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Moradi M., Shahabi J., Vakhshoori M., Shafie D. Associated factors with the occurrence of inappropriate shocks among admitted patients with ischemic cardiomyopathy. ARYA Atheroscler. 2022;18(10):1–7. DOI: 10.48305/arya.2022.11742.2372.</mixed-citation><mixed-citation xml:lang="en">Moradi M., Shahabi J., Vakhshoori M., Shafie D. Associated factors with the occurrence of inappropriate shocks among admitted patients with ischemic cardiomyopathy. ARYA Atheroscler. 2022;18(10):1–7. DOI: 10.48305/arya.2022.11742.2372.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Defaye P., Boveda S., Klug D., Beganton F., Piot O., Narayanan K. et al. Dualvs. single-chamber defibrillators for primary prevention of sudden cardiac death: long-term follow-up of the Defibrillateur Automatique Implantable-Prevention Primaire registry. Europace. 2017;19(9):1478– 1484. DOI: 10.1093/europace/euw230.</mixed-citation><mixed-citation xml:lang="en">Defaye P., Boveda S., Klug D., Beganton F., Piot O., Narayanan K. et al. Dualvs. single-chamber defibrillators for primary prevention of sudden cardiac death: long-term follow-up of the Defibrillateur Automatique Implantable-Prevention Primaire registry. Europace. 2017;19(9):1478– 1484. DOI: 10.1093/europace/euw230.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Peterson P.N., Greenlee R.T., Go A.S. Comparison of inappropriate shocks and other health outcomes between singleand dual-chamber implantable cardioverter-defibrillators for primary prevention of sudden cardiac death: results from the Cardiovascular Research Network Longitudinal Study of Implantable Cardioverter-Defibrillators. J. Am. Heart Assoc. 2017;6(11):e006937. DOI: 10.1161/JAHA.117.006937.</mixed-citation><mixed-citation xml:lang="en">Peterson P.N., Greenlee R.T., Go A.S. Comparison of inappropriate shocks and other health outcomes between singleand dual-chamber implantable cardioverter-defibrillators for primary prevention of sudden cardiac death: results from the Cardiovascular Research Network Longitudinal Study of Implantable Cardioverter-Defibrillators. J. Am. Heart Assoc. 2017;6(11):e006937. DOI: 10.1161/JAHA.117.006937.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Burger A.L., Schmidinger H., Ristl R., Pezawas T. Appropriate and inappropriate therapy in patients with singleor multi-chamber implantable cardioverter-defibrillators. Hellenic J. Cardiol. 2020;61(6):421–427. DOI: 10.1016/j.hjc.2020.03.001.</mixed-citation><mixed-citation xml:lang="en">Burger A.L., Schmidinger H., Ristl R., Pezawas T. Appropriate and inappropriate therapy in patients with singleor multi-chamber implantable cardioverter-defibrillators. Hellenic J. Cardiol. 2020;61(6):421–427. DOI: 10.1016/j.hjc.2020.03.001.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
